Rose Elisabeth Lunde holds her PhD defense on Friday, November 7th.
2025
A collaboration between the Norwegian Research Council (NFR)-funded research projects PriSUD (SERAF, UiO) and ULTPEN (NTNU and KRUS) uncovers an overwhelming and complex burden of mental health disorders among individuals sentenced to preventive detention (forvaring) in Norway.
SERAF Expresses Gratitude to Drs. Jennifer Edelman and Patrick O’Connor
Patient's self-assessment: Better mental health – but uncertain effect on anxiety and depression after a year in heroin-assisted treatment
Håkon Høydal Nestvold will defend his PhD thesis on Friday September 12.
A new SERAF study shows the connection between the use of strong painkillers and substance use disorders.
SERAF has updated its systematic review on sustained-release naltrexone in The Cochrane Library.
Opioid Prescribing in Scandinavia, 2010–2023: Similar Challenges, Different Paths
Patient satisfaction in OAT is related to the content and structure of the treatment, as well as to the patient's substance use during treatment
In a collaboration with Oslo University Hospital, Thomas Clausen has contributed to a new publication in the Scandinavian Journal of Primary Health Care.
A new study from the POINT project and KORFOR shows that the use of the strong pain-relieving opioid oxycodone has significantly increased in Norwegian hospitals and primary healthcare services over the past ten years. The study has been published in the European Journal of Pain.
Researchers from SERAF and Sørlandet Hospital recently published a qualitative study on aging in opioid agonist treatment in Norway.
Today, EUDA released data from the "European Web Survey on Drugs (EWSD) 2024" to which Norway also contributed data collection.
On Wednesday, January 29, 2025, Ivar Skeie was awarded the King's Medal of Merit during a medal ceremony organized by SERAF at the University of Oslo.
Friday, January 17th Espen Woldsengen Haugom will defend his PhD thesis at Rikshospitalet.